You think investors will come flooding in if they release some scan images to market. Did these investors not believe the clinical data? They need to see and interpret MRI images themselves before investing?
Great to see this trial enrolling 2nd line patients. That, coupled with multiple trial sites, will mean the enrollment rate should be much faster.
Plus we get to see if we get additional benefit at 2nd line.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)